ClinicalTrials.Veeva

Menu

To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease

M

Maastricht University

Status

Completed

Conditions

Usual Interstitial Pneumonia
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease

Treatments

Diagnostic Test: radiomics

Study type

Observational

Funder types

Other

Identifiers

NCT04430491
RESPIRE_2019

Details and patient eligibility

About

To investigate the ability of machine learning models based on radiomic features extracted from thin-section CT images to differentiate IPF patients from non-IPF interstitial lung diseases.

Enrollment

300 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • UIP with final diagnosis in biopsy
  • ILDs with final diagnosis in biopsy

Exclusion criteria

  • patients with no biopsy confirmation

Trial design

300 participants in 2 patient groups

Training dataset
Description:
No interventions
Treatment:
Diagnostic Test: radiomics
Validation dataset
Description:
No interventions
Treatment:
Diagnostic Test: radiomics

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems